US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist

1.260
+0.070+5.88%

Close Aug 23 16:00 ET

1.260
0.0000.00%

Post 18:07 ET

173.36MMarket Cap-3600P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	850.000K / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q2850.000K / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Compass Therapeutics Earnings Reports

Compass Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 08:05 ET

Compass Therapeutics | 10-Q: Q1 2024 Earnings Report

May 13 08:04 ET

Compass Therapeutics | 10-K: FY2023 Annual Report

Mar 21 09:06 ET

Compass Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 07:30 ET

Analyst Rating

Updated: Aug 13, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall